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012.08.0Abstract Background and aim: Culture-negative infective endocarditis (CNIE) is a diagnostic
dilemma. The study was carried out to estimate the prevalence of CNIE among deﬁnite IE cases,
to describe the epidemiologic and clinical characteristics of CNIE patients and to diagnose the
microbial etiology of CNIE using molecular and serological techniques.
Subjects and methods: Sixty-ﬁve deﬁnite IE cases were enrolled in a prospective observational study
between January and December 2010. CNIE cases were tested by 16SrRNA and seminested PCR
for 35 blood samples, serological tests and the study of ten valve tissue specimens.
Results: CNIE constituted 39 (60%) cases. The mean age of CNIE patients was 31 years. Male to
female ratio was 2.9:1. Healthcare associated IE accounted for 15.4%, native valve IE for 66.7%
and intravenous drug abuse for 20.5% of cases. The mitral valve was the most frequently involved
(56.4%). Out of 39 CNIE cases, seminested blood PCR detected 12 cases (ten Staphylococci, two
Streptococci). Five cases were reactive by serology (three Bartonella, one Coxiella, and one
Brucella). Six cases were positive by analysis of valve tissue (three Staphylococci, three Streptococci).
The combined results of all diagnostic tools decreased the percentage of non-identiﬁed causes of
CNIE from 60% to 24.6%.
Conclusions: Our data underlined the role of collecting blood culture before starting antibiotics and
the role of seminested PCR in the diagnosis of conventional causes of CNIE. The importance of
serology to identify non conventional causes was also highlighted.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.005667342.
com (M.A. Meheissen).
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011. Introduction
Infective endocarditis (IE) is an uncommon but serious and of-
ten life-threatening condition. The overall incidence of IE has
remained relatively stable for about 3.6–7.0 cases per 100,000g by Elsevier B.V. All rights reserved.
146 S.M. Sadaka et al.patient-years.1 Despite the introduction of improved, often
automated, blood culture systems and the development of im-
proved culture media, studies have indicated that this ap-
proach fails to identify an etiologic agent in 2.5–31% of
cases. These negative cultures result in the classiﬁcation of such
cases as blood culture-negative infective endocarditis (CNIE).2
The proportion of CNIE varies from country to country and
among different centers in the same country. These variations
reﬂect the local epidemiology of IE, diagnostic criteria used,
initiation of antibiotics in patients prior to obtaining blood
cultures, and the diagnostic protocol used to establish an etiol-
ogy.3 This situation is a major problem for the choice of the
optimal antibiotic regimen, which should be as speciﬁc and
efﬁcient as possible for this life-threatening disease. In view
of a changing epidemiology and a growing number of resistant
strains, the correct diagnosis of IE-causing pathogens has be-
come even more important. Furthermore inadequate therapy
carries the risk of relapse or re-infection after heart valve
replacement, with a poor prognosis.4
Two main reasons account for CNIE. First, in many critical
clinical situations, empirical antibiotic therapy is administered
prior to diagnosis or even before the patient is suspected of
having IE. Blood cultures drawn under antibiotic treatment
have a signiﬁcantly lower sensitivity. Second, fastidious or
yet uncultured microorganisms that are regularly missed by
routine culture methods may be involved in CNIE cases.2
Considerable efforts have been made to establish the etio-
logical diagnosis of CNIE. PCR ampliﬁcation of universal
rRNA loci and speciﬁc gene targets for bacteria has been done
in blood, as well as in valve material from patients with
CNIE.5 The main limitation of studies performed in heart
valves is that they are proﬁtable only for patients needing sur-
gery. Theoretically, the ideal rapid diagnosis of CNIE by
broad range PCR would be performed in circulating blood,
including that of patients with IE who do not require valvular
surgery.6 However, to date, the studies performed on blood
samples are scarce and their utility has been hampered by
low analytical sensitivity and the presence of contaminant
DNA in PCR reagents.7–9
Serological tests are now included as diagnostic criteria for
IE in the modiﬁed Duke criteria.10 Testing for CNIE includes
the systematic determination of antibody titers against Coxi-
ella burnetii, Bartonella spp., Chlamydia spp., Brucella meliten-
sis, Mycoplasma pneumoniae, and Legionella pneumophila
which are among the most common pathogens in CNIE. How-
ever, in other instances, one must be cautious when relying so-
lely on serologic methods to diagnose endocarditis because of
cross-reactions.2
This study was conducted to estimate the prevalence of
CNIE among deﬁnite IE cases in Alexandria Main University
Hospital, to describe and analyze clinical data from CNIE pa-
tients and to diagnose the microbial etiology of CNIE by using
molecular and serological techniques.2. Patients and methods
Sixty-ﬁve patients admitted to the Cardiology as well as to the
Cardiothoracic Surgery Departments of Alexandria Main
University Hospital (AMUH), with deﬁnite IE according to
modiﬁed Duke criteria were enrolled in a prospective, observa-
tional study starting from January 2010 through December2010. The study protocol was approved by the Ethics Commit-
tee of AMUH. Informed written consent was obtained from all
study subjects before enrollment in the study.2.1. Data collection
A structured sheet was used to collect the following clinical,
laboratory and echocardiographic data of the patients: name,
age, gender, type of work (contact with animals), predisposing
and triggering factors, history of previous attacks, clinical
manifestations and complications, the affected valve, echocar-
diography results, patient outcome, and history of previous
antibiotic intake.2.2. Sample collection
Three blood samples were withdrawn simultaneously from all
patients under strict aseptic technique; 10 ml blood in Oxoid
signal blood culture system for blood culture (Three blood
cultures were taken for each patient separated by at least
one hour), 3 ml blood in EDTA tubes for molecular testing
and 3 ml blood in plain tubes for serology. Bottles and tubes
were rapidly delivered to the Microbiology laboratory of
AMUH where Oxoid signal blood bottles were incubated
at 37 C, EDTA tubes were stored at 4 C till DNA extrac-
tion (maximum 72 h after specimen collection) and plain
tubes were used to separate serum samples which were then
stored at 20 C. Blood culture was carried out according to
manufacturer’s instructions and bacterial identiﬁcation
was performed according to standard microbiological
procedures.11
2.3. Molecular tests from whole blood samples for CNIE
2.3.1. Broad range bacterial 16S rRNA PCR assay12,13
DNA was extracted from whole blood with EZ-10 spin column
genomic DNA minipreps kit, Blood, BS483 (Bio Basic Inc.,
Canada) according to the manufacturer’s instructions.
Five microliter of DNA extract was ampliﬁed in a 25 ml
volume PCR reaction using the oligonucleotide primer set
DG74:50-AGG AGG TGA TCC AAC CGC3-0 and RW01:
50-AACTGG AGG AAG GTG GGG AT3-0. These broad
range PCR primers are located at the nucleotide positions
1522–1540 and 1170–1189 within the Escherichia coli 16S
rRNA genes respectively. The PCR reaction consisted of
12.5 lL DreamTaq Green PCR Master Mix (2X) (Fermen-
tas), 30 pmol DG74 and RW01 each, and PCR grade water
to a ﬁnal volume 25 lL. The PCR ampliﬁcation consisted of
an initial denaturation step at 95 C for 5 min followed by
35 cycles of denaturation at 95 C for 30 s, annealing at
60 C for 30 s, extension at 72 C for 30 s and ﬁnal extension
at 72 C for 10 min. (Techne Genius, Cambridge, UK). The
PCR products were electrophoresed through a 2% (w/v)
molecular biology grade agarose gel (Conda, Pronadisa) in
Tris–Borate EDTA buffer, pre-stained with ethidium bromide
(0.5 mg/ml) for 45 min. Molecular sizes of the amplicons were
determined by comparison to a 100–1000 bp DNA ladder. A
positive result was inferred by detection of 371 bp band.
An internal control was added into each 16S rRNA PCR
vial. BGF: 50-CAACTTCATCCACGTTCACC-30 and BGR:
50-GAAGAGCCAAGGACAGGTAC-30 in a concentration
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man b-globin gene.
Positive controls for Gram positive bacteria (Staphylococ-
cus aureus), Gram negative bacteria (Escherichia coli), and po-
sitive blood sample taken from a patient with S. aureus
endocarditis, as well as, an extraction negative control (dis-
tilled water instead of blood sample) and master mix negative
control (distilled water instead of DNA template) were also in-
cluded into every PCR reaction. These controls enabled mon-
itoring of PCR performance and speciﬁcity, as well as checking
for crossover and carryover contamination.
The sensitivity of the broad range PCR assay, including
the efﬁciency of DNA extraction, was tested using blood
samples spiked with known concentrations of S. aureus (S.
aureus) determined using a modiﬁcation of the Miles and
Misra technique. Tenfold serial dilution was done till reach-
ing a concentration of one CFU of bacteria per 1 mL of
blood. After DNA extraction and PCR, agarose gel electro-
phoresis was used to establish the lowest number CFU/ml
of blood that is required to generate a band visible by ethi-
dium bromide staining.14
The occurrence of false-negatives due to the presence of
inhibitory substances in the whole blood extract was investi-
gated by performing PCR ampliﬁcation on PCR-negative tem-
plate samples inoculated with staphylococcal DNA extract.
The PCR-negative samples were ‘spiked’ with 5 · 104 CFU
DNA extract per 25 lL PCR reaction. Ampliﬁcation was per-
formed by the standard PCR protocol. PCR inhibition was
indicated by the failure of PCR to generate an amplicon from
template spiked with bacterial DNA extract.12
2.3.2. Seminested PCR assays15
Five microliter of each broad range 16S rRNA PCR product
was further identiﬁed in separate ampliﬁcation reactions using
the genus or species speciﬁc primers of Streptococcus spp.,
S. aureus and coagulase negative Staphylococcus (CONS)
spp. The primers used were initially designed and used as
probes by Greisen et al.16 They anneal to genus or species-spe-
ciﬁc internal sequences within the 371-bp region of the detected
bacteria obtained using universal primers RW01 and DG74.
For Streptococcus spp., the primer pair 50-AAC TGA GAC
TGG CTT TAA GAG ATT A-30 and RW01 was used. These
primers ﬂank a 132-bp region within the 16SrRNA gene of
Streptococcus spp. For S. aureus, the primer pair 50-GCC
GGT GGA GTA ACC TTT TAG GAG C-30 and DG74
was used. These primers ﬂank a 105-bp region within the
16SrRNA gene of S. aureus. For CONS, the primer pair 50-
CGA CGG CTA GCT CCA AAT GGT TAC T-30 and
RW01 was used. These primers ﬂank a 297-bp region within
the 16SrRNA gene of CONS. The reaction conditions were
the same as those used in the 16S rRNA PCR.
2.4. Serological tests from serum samples of CNIE cases3
Serum samples were subjected to serological assays to detect
speciﬁc antibodies to Coxiella burnetii, Bartonella henselae
and Bartonella Quintana using immunoﬂuorescence assay
(IFA) (Vircell, Spain), and to Brucella spp. by BRUCELLAC-
APT (Vircell, Spain) according to the manufacturer’s instruc-
tions. The cutoff titer to diagnose IE was 1/800 for phase I
C. burnetii IgG and for Bartonella IgG, while that for Brucella
was 1/160.2.5. Laboratory processing of valve tissue samples of CNIE
cases17
Excised valvular material was aseptically divided for further
analysis in the operating theater by the surgeon: (1) A sample
for PCR analysis and valve staining in a DNA-free and sterile
container without any additive. The sample was frozen within
45 min at 20 C till DNA extraction. (2) The remaining tissue
was aseptically transferred to a bottle containing 50 ml thiogly-
collate broth (Oxoid, UK) and transferred as soon as possible
to the microbiology laboratory for incubation at 37 C.
2.5.1. Direct smears and valve cultures
A smear of each valve tissue sample, after grinding, was pre-
pared and stained using Gram stain. The section of heart valve
tissue that was transferred to a sterile bottle containing 50 ml
of thioglycollate broth was incubated for 3 weeks at 37 C.
Subsequently subcultures were done on day 2, 7 and 21 onto
a range of microbiology media, including blood agar, choco-
late agar (Columbia agar base supplemented with 5% deﬁbrin-
ated blood, Oxoid), and blood agar inoculated in its middle
with S. aureus. These plates were incubated for 18 h in a 5%
enriched CO2 at 37 C. Subculture was also done on
MacConkey’s agar incubated aerobically at 37 C, fungal med-
ia (Sabouraud dextrose agar, Oxoid) incubated aerobically at
30 C. Subculture was done on one chocolate agar plate and
the plate was incubated anaerobically for at least 48 h at
37 C. All isolates were identiﬁed by morphology and standard
microbiological methods.11
2.5.2. Molecular tests from valve tissues
Native valve tissue samples (a piece of the valve, vegetation, or
abscess) were cut into small pieces using a sterile scalpel blade,
homogenized in a sterile physiological solution, and a 200 ll
aliquot of this suspension, was puriﬁed on a spin column
(QIAamp blood kit; Qiagen, Hilden, Germany). Prosthetic
valves were carefully scraped with a scalpel and then vigor-
ously washed in a sterile physiological solution. The suspen-
sion obtained was then subjected to DNA extraction
procedure using a spin column (QIAamp blood kit; Qiagen,
Hilden, Germany). Broad range bacterial 16SrRNA and
seminested PCR assays were performed with blood
samples.12,133. Results
3.1. Clinical and demographic data
Patients were considered to have deﬁnite CNIE if the results of
standard blood cultures were negative and if clinical and echo-
cardiographic ﬁndings met the modiﬁed Duke Endocarditis.
Among the 65 deﬁnite IE cases, 39 (60%) patients had one ma-
jor and three minor criteria and were classiﬁed as deﬁnite
CNIE.
The mean age of CNIE patients was 31 years. Male to fe-
male ratio was 2.9:1. Endocarditis was considered nosocomial
healthcare-associated IE (HCA-IE) when developed in a pa-
tient hospitalized for more than 48 h prior to the onset of signs
and symptoms consistent with endocarditis. Non-nosocomial
HCA-IE was deﬁned as endocarditis with the onset of speciﬁc
symptoms within 48 h of admission in a patient with health
148 S.M. Sadaka et al.care contact.18 HCA-IE accounted for six (15.4%) episodes
(one nosocomial and ﬁve non-nosocomial). Native valve IE
(NVE) accounted for 26 (66.7%) cases, while prosthetic valve
IE (PVE) constituted 12 (30.8%) cases and intracardiac devices
one (2.6%) case. The mitral valve was the most frequently in-
volved, affecting 22 (56.4%) cases, followed by the tricuspid
and aortic valves affecting eight (20.5%) and six (15.4%) cases
respectively. Combined aortic/mitral valve affection was seen
in two (5.1%) cases. One patient (2.6%) was on a pacemaker.
The most common underlying heart disease was rheumatic
heart disease (RHD), which was responsible for 64.1% (25
cases) of all CNIE, followed by non-rheumatic valvular heart
diseases and mitral valve prolapse (MVP) (2 cases each)
5.1% each, and one congenital heart disease (2.6%). Two pa-
tients (5.1%) experienced a previous IE attack. Intravenous
drug abuse (IVDA) accounted for eight cases (20.5%). There
was no predisposing heart disease or previous risk factor in
only one patient (2.6%). All CNIE patients (100%) had re-
ceived a previous antibiotic course before being admitted to
our hospital. (Figs. 1 and 2).
The mean time between onset of symptoms and diagnosis
of IE was 39 days (total range 3–210 days). All symptoms
and signs were nonspeciﬁc and occurred in a signiﬁcant num-
ber of patients. Fever was the most common symptom (100%)
at initial evaluation. Other major symptoms were dyspnea, fa-
tigue, arthralgia, headache, chills, anorexia, weight loss and
low back pain. The most frequent sign found at the initial0
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Figure 1 Predisposing factors in CNIE patients. (RHD: rheu-
matic heart disease, CHD: congenital heart disease, MVP: mitral
valve prolapse, NRVD: non-rheumatic valvular disease, IVDU:
intravenous drug user).
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Figure 2 Type of IE in CNIE patients. (CA-IE: community
acquired IE, HCA-IE: health care acquired IE, NVE: native valve
endocarditis, PVE: prosthetic valve endocarditis, PME: pace-
maker endocarditis).examination was heart murmur (84.6%). Anemia was present
in 95% of patients, and the inﬂammatory parameters (ESR,
CRP) were constantly elevated. Peripheral signs like splinter
hemorrhage, clubbing of the ﬁngers, Janeway lesion and Os-
ler’s node were not observed. Complications were found in
17 (43.6%) patients. Manifestations of heart failure were
found in 11 patients (28.2%). Major embolic events (cerebral,
pulmonary and peripheral) were present in 12 patients
(30.8%). One patient had periannular abscess and another pa-
tient had renal failure. Some patients presented with more than
one complication. The endocarditis associated mortality was
observed in ﬁve (12.8%) CNIE. The major causes of mortality
included neurological and cardiovascular complications.
3.2. Microbiological results
Out of 39 CNIE patients, 29 whole blood and serum samples
were collected from 29 CNIE patients and 10 valve tissue sam-
ples were procured during valve replacement, corresponding to
10 surgically treated patients. Six surgically treated patients
had corresponding blood and serum samples and four patients
had only valve specimens but conﬁrmed results of negative
blood cultures, collected before surgery, were evaluated retro-
spectively in these four patients. So, out of the 39 CNIE pa-
tients, 35 blood and serum samples as well as 10 valvular
samples were collected.
3.2.1. Whole blood PCR results
3.2.1.1. Broad range bacterial 16S rRNA PCR results. PCR
ampliﬁcation of 16S rRNA showed negative results with all
tested whole blood samples. No inhibition of PCR was de-
tected; b-globin amplicons were obtained in all cases (Fig. 3).
The ampliﬁcation sensitivity assay using whole blood
spiked with S. aureus demonstrated that 2.5 · 10 bacteria perFigure 3 Agarose gel electrophoresis for whole blood broad
range 16S rRNA. A band of 371 bp corresponds to 16S rRNA
DNA and a band of 268 bp corresponds to internal control b-
globin DNA. Lane 1: molecular size DNA marker (100–1000 bp);
lane 2: S. aureus ATCC 25923 positive control (371 bp); lane 3:
Escherichia coli ATCC 25922 positive control (371 bp); lane 4:
positive blood sample control (268 and 371 bp); lane 5 and 6:
negative blood samples results (268 bp); lane 7: extraction negative
control; lane 8: master mix negative control.
Figure 4 Agarose gel electrophoresis for whole blood seminested
PCR. A band of 105, 132, and 297 bp corresponds to S. aureus,
Streptococcus spp. and CONS spp. DNA respectively. Lane 1:
molecular size DNA marker (100–1000 bp); lane 2: S. aureus
ATCC 25923 positive control (105 bp); lane 3: S. aureus positive
sample (105 bp); lane 4: S. pneumoniae ATCC 49619 positive
control (132 bp); lane 5: Streptococcus spp. positive sample
(132 bp); lane 6: Staphylococcus epidermidis ATCC 12228 positive
control (297 bp); lane 7: CONS positive sample (297 bp).
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able PCR amplicon. No false negatives were detected due to
the presence of inhibitory substances in whole blood extract
as proved by positive ampliﬁcation of all negative PCR sam-
ples spiked with staphylococcal DNA.
3.2.1.2. Seminested PCR results. The semi-nested PCR assay
detected DNA from 12 out of 35 blood specimens (34.3%).
Identiﬁed bacteria were as follows: Eight (66.6%) S. aureus,
two (16.7%) CONS and two (16.7%) Streptococcus spp.
(Fig. 4) The combined results of PCR assays applied on CNIE
blood specimens succeeded to identify the causative agent of
CNIE in 12 out of 35 patients (34.3%). Thus, the percentage
of CNIE patients with no identiﬁed etiology dropped from
60% to 41.5% by considering the PCR results.
3.2.2. Serology results
A positive reactive Bartonella IFA test result was observed for
three patients. One patient had Bartonella henselae IgG
titerP 1:3200 and Bartonella quintana IgG titer equals to
1600, another patient had B. henselae IgG titer P1:3200 and
B. quintana IgG titer equals to 400, a third patient had B.
henselae IgG titer P1:3200 while B. quintana IgG titer was
negative. We considered the three patients as possible B. hense-
lae endocarditis. Another patient had a typical proﬁle of Q fe-
ver endocarditis (Phase I: IgGP 3200; IgM 48 and IgAP 192
/Phase II: IgGP 3200; IgM negative and IgAP 192) as
proved by C. burnetii IFA test. A positive Brucella serologic
result with titers ofP5120 was observed for one patient using
BRUCELLACAPT agglutination test. Therefore, the com-
bined results of all serological tests applied on CNIE serum
specimens succeeded to implicate a causative agent of CNIE
in (5/35) 14.3% of patients, decreasing the percentage of CNIE
patients with no identiﬁed etiology to 52.3%.3.2.3. Valve tissue testing results
When excluding the two contaminated valves, the sensitivity of
different tests used for valve analysis was as follows: valve
Gram staining (2/8; 25%), valve culture (5/8; 62.5%), valve
16S rRNA PCR (6/8; 75%). This decreases the percentage of
CNIE patients with no identiﬁed etiology from 60% to
50.8% (Table 1).
In 59% (23/ 39) of CNIE patients, we were able to identify
the bacteria to the species and/or genus level using all diagnos-
tic tools. This was possible by PCR analyses of whole blood
samples, serological testing, culturing materials obtained from
cardiac valves and PCR analyses of valves in 12/35, 5/35, 5/8
and 6/8 cases, respectively. An etiologic agent could not be
determined for 16 (41%) of CNIE cases (Table 2). Thus, the
combined results of all diagnostic tools used in our study, de-
creased the percentage of non-identiﬁed causes of CNIE from
60% to 24.6%.4. Discussion
In our study, the mean age of CNIE patients was 31 years
which reﬂects the effect of rheumatic fever and its sequelae
on the heart. The same young mean age was also observed in
other CNIE studies.19,20 In contrast with CNIE reports from
Europe in which CNIE cases occurred in patients over the
age of 50 years.5,21 Male: female ratio was 2.9:1. Male sex pre-
dilection has been observed in previous CNIE studies.19–21
In the present study, 15.4% of cases were HCA-IE. HCA-
NVE currently accounts for more than one third of all cases
of NVE in non-injection drug users throughout much of the
world.22 Our CNIE group included a large proportion of
PVE (30.8%) in agreement with the study of Rizk et al.20
which reported a similar proportion (37.7%). The commonest
valve affected was the mitral valve (56.4%) which is likely due
to the predilection of mitral valve by rheumatic heart disease
which represented the majority of our patients. Right-sided
IE affecting the tricuspid valve accounted for 20.5% of our pa-
tients, it has been suggested that a signiﬁcant increase in the
proportion of right-sided IE in our study is related to IVDA.
According to our study, RHD remains the most common
underlying heart disease as indicated by a positive past history
in 64.1% unlike western countries where the incidence of rheu-
matic fever has decreased23,24 MVP has been reported as a
common underlying heart lesion in western studies23,25 but
constituted only a small fraction in our study (5.1%). The pro-
portion of CNIE patients without previously known cardiac
disease or risk factor was 2.6% only. This is in contrast to
other studies26,27 where half of their cases belonged to this cat-
egory. Antibiotic treatment preceded blood culture in 100% of
our CNIE episodes. It differs from other studies that report on
the previous antibiotic treatment in 45–50% of episodes.21,28
The mean duration elapsed between the beginning of the
clinical picture and the deﬁnite diagnosis of IE was 39 days
which is longer than earlier reports studying CNIE.21 Among
the presenting symptoms, fever was observed in all patients
(100%), in contrast to previous CNIE studies where fever
was not present in all cases.5,19 When comparing our CNIE
group with other CNIE series5, our rate of heart failure was
less (28.2% vs 50%); while the rates of major embolic events
(cerebral, pulmonary and peripheral) were almost similar
(30.8% vs 29%).
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150 S.M. Sadaka et al.Blood culture was negative in 5–90% of IE patients in pre-
vious studies.29–33 We reported a high rate of CNIE (60%) in
our study as reported from developing countries. We realize
that the main reason of negative blood cultures in our study
was prior administration of antibiotics, so that the introduc-
tion of an automated blood culture system in our hospital is
mandatory for proper diagnosis of IE.
In the present study, the 16S rRNA PCR assay was nega-
tive with all blood samples. The negative result obtained could
be due to the presence of a lower number of microorganisms in
the sample or, probably, due to failure to detect bacteria pres-
ent in a sample at a level below the sensitivity of the conven-
tional PCR method. We tried to determine whether false-
negative results could have been avoided by analyzing multiple
samples, larger blood volumes, larger DNA extract or even
increasing the number of PCR cycles, but this was not success-
ful. On the contrary this resulted in false positive results
(ampliﬁcation of environmental contaminants; Bacillus spp.)
conﬁrmed by sequencing. Specimen storage might be an alter-
native explanation. Some of our sample extracts were stored
for six months till PCR was performed. Fenollar et al.34 re-
ported that the sensitivity of their PCR assay was strongly af-
fected by serum storage at 20 C, most likely through the
progressive degradation of frozen DNA. The inhibition of
the PCR reaction was previously reported by Goldenberger,35
as a potential cause of negative PCR result. However, in the
present study, we applied all measures (internal b-globin gene,
positive controls) to exclude inhibition of PCR reaction, also,
no false negatives, due to the presence of inhibitory substances
in blood, were detected as proved by positive ampliﬁcation of
all negative PCR samples spiked with staphylococcal DNA.
Fournier PE et al.36 reported that the PCR output varied
depending on specimens. When applied to blood, 16S rRNA
ampliﬁcation exhibited a poor sensitivity, with 35 positive
specimens of 257 tested (13.6%). Valvular biopsies, when
available, proved to be of great diagnostic value, the 16S
rRNA PCR assays of valves allowed the detection of a micro-
organism in 150 out of 227 patients (66.1%). Similarly, in the
study of Casalta et al.,37 among the 20 CNIE patients previ-
ously treated with antibiotics, the SeptiFast test has detected
only three bacteria. Based on the results of the previous studies
and taking into consideration that we tested a conventional
PCR and not a real time assay, the negative results of our
16S rRNA PCR assay are not surprising.
The sensitivity of the different PCR assays was different
among studies. In the study of Ley et al.,14 the PCR methods
detected 4.3 · 103 colony-forming units (CFU) of E. coli per
mL of spiked whole blood. Casalta et al.37 reported that the
analytic sensitivity of the SeptiFast assay was tested using bac-
terial dilutions of 100, 30, and 3 CFU/ml in EDTA blood. A
minimum sensitivity of 30 CFU/ml was obtained for most
the species. Our 16S rRNA PCR detected 2.5 · 10 CFU of S.
aureus per mL of spiked whole blood. Although successful
ampliﬁcation of the PCR product after spiking bacteria in
the blood demonstrates the sensitivity of the assay, this does
not guarantee reproducible ampliﬁcation of the pathogen
DNA in true IE bacteremia, in which the number of organisms
tends to be low with the previous antibiotic intake.
We included speciﬁc primers for S. aureus, CONS and
Streptococcus spp., the most encountered bacterial etiological
agents of CNIE due to previous antibiotic treatment, in a
seminested PCR assay using the same 16S rRNA primers in
Table 2 Identiﬁed pathogens obtained with different diagnostic tests in 39 CNIE patients.
Whole blood broad
range PCR
Whole blood
seminested PCR
Serology Valve culture Valve broad
range PCR
Valve seminested
PCR
S. aureus (n= 9) – 8 ND 1 1 1
CONS (n= 4) – 2 ND 2 2 2
Streptococcus spp (n= 5) – 2 ND 2 3 3
Coxiella burnetii (n= 1) – ND 1 ND – ND
Bartonella henselae/B. quintana (n= 3) – ND 3 ND – ND
Brucella spp. (n= 1) – ND 1  – ND
: negative, ND: not done.
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species of the causative organism in one step. The same assay
was previously tested on cerebrospinal ﬂuid samples for the
diagnosis of bacterial meningitis.15,16 The seminested PCR as-
say allowed the diagnosis of 12 out of 35 CNIE (34.3%). To
the best of our knowledge this is the ﬁrst time to apply a semin-
ested PCR assay on whole blood samples for the diagnosis of
CNIE.
In the present study, etiologic agents identiﬁed by serology
constituted 12.8% of identiﬁed causes of CNIE. Bartonella was
implicated in 7.7% of CNIE cases, while C. burnetii and Bru-
cella represented 2.6% of CNIE cases each. Our results were
consistent with the results of Cairo University20 which re-
ported 53 CNIE cases with 9.4% of cases caused by Bartonella
and C. burnetii. Moreover, 10% of cases of IE in Tunisia were
caused by C. burnetii and Bartonella.38 Our ﬁndings are not in
agreement with the results the French National Reference Cen-
ter for Rickettsial Diseases study39 which reported 348 cases of
CNIE with 48% of cases caused by C. burnetii and 28% by
Bartonella. Also, in Algeria, C. burnetii, B. melitensis, and B.
quintana constituted one quarter of the performed diagno-
ses.40 In our study, the low prevalence of Coxiella and Barton-
ella could be attributed to differences in living conditions, or
animal exposure, or availability of louse borne infections in
our country.
Comparative results from recent studies using molecular
approach indicate the clear superiority of valve material
PCR over conventional valve culture and microscopy.41 This
is in agreement with our results where the sensitivity of valve
PCR (75%) exceeded that of valve culture (62.5%) and valve
microscopy (25%). An explanation for the negative PCR re-
sults in the two CNIE valve cases might be that only parts
of the infected heart valve tissue was subjected to DNA extrac-
tion. It is therefore possible, that the actual infected site was
not analyzed as the two patients had prosthetic valves. On
the other hand, we reported one CNIE case positive by valve
PCR for Streptococcus spp. while negative by valve culture;
this could be attributed to previous antibiotic therapy which
inhibited the growth of fastidious streptococci. Similarly, Boss-
hard et al.42 found that the results of PCR for three patients
were positive, even though the results of microscopic examina-
tion, and culture of endocardial specimens were negative.
An unexpected ﬁnding of previous CNIE studies was the
identiﬁcation of patients with non-infective endocarditis asso-
ciated with cancers and autoimmune diseases.36,43,44 In our
study we did not evaluate the presence of non-infective endo-
carditis and it is possible that some of the 16 CNIE cases with
unidentiﬁed etiology belong to this category. Further, previous
authors reported that truly negative IE is far less frequent thaninitially expected.5,39 We could not estimate the percentage of
truly CNIE cases in our study, as we did not search for all pos-
sible etiological agents of CNIE identiﬁed either by serology
(for example Legionella, Mycoplasma, Chlamydia), or PCR
analysis (enterococci, HACEK, Gram negative bacilli, fungi).
5. Conclusions
CNIE may be a diagnostic dilemma but in many cases the
causative pathogen can be determined. Proper collection of
blood culture before starting antibiotics, as well as, the use
of an automated blood culture system will improve etiological
diagnosis of IE. PCR offers a very good opportunity to diag-
nose CNIE from blood samples especially in case of previous
antibiotic therapy. The results obtained by seminested PCR
should be acceptable as a starting point for optimization of
the method for diagnosis of CNIE. Serum samples should
always be tested for antibodies to fastidious organisms, and
excised valves or vegetations should undergo microscopy,
culture, and relevant PCR analysis.
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